Skip to main content

MARSH & MCLENNAN COMPANIES, INC.

For the period ended Jun 30, 2026. Filed Jul 21, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 21, 2026

MRSH$206.94+1.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Six Months Ended June 30,
(In millions)20262025
Operating cash flows:
Net income before non-controlling interests$2,477$2,643
Adjustments to reconcile net income provided by operations:
Depreciation and amortization of fixed assets and capitalized software179179
Amortization of intangible assets275279
Non-cash lease expense151145
Adjustments and payments related to contingent consideration assets and liabilities(33)11
Gain on consolidation of entity—(13)
Net (gain) on investments(1)(12)
Net (gain) on disposition of assets(7)(15)
Share-based compensation expense235210
Changes in assets and liabilities:
Net receivables(1,365)(921)
Other assets(154)(69)
Accrued compensation and employee benefits(1,319)(1,334)
Provision for taxes, net of payments and refunds169190
Contributions to pension and other benefit plans in excess of current year credit(123)(117)
Other liabilities52138
Operating lease liabilities(170)(165)
Net cash provided by (used for) operations8351,049
Financing cash flows:
Purchase of treasury shares(1,512)(600)
Net proceeds from issuance of commercial paper1,024150
Proceeds from issuance of debt595—
Repayments of debt(610)(510)
Payment to acquire non-controlling interest(54)—
Shares withheld for taxes on vested units – treasury shares(123)(142)
Issuance of common stock from treasury shares91175
Payments of deferred and contingent consideration for acquisitions(61)(43)
Receipts of deferred and contingent consideration for dispositions12—
Distributions of non-controlling interests(30)(34)
Dividends paid(878)(810)
Change in fiduciary liabilities860(19)
Net cash provided by (used for) financing activities(686)(1,833)
Investing cash flows:
Capital expenditures(134)(114)
Purchases of long-term investments(9)(15)
Sales of long-term investments184
Dispositions1215
Acquisitions, net of cash and cash held in a fiduciary capacity acquired(129)(62)
Other, net(6)(3)
Net cash provided by (used for) investing activities(265)(95)
Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity(141)753
Increase (Decrease) in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity(257)(126)
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period14,16013,674
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period$13,903$13,548
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity to the Consolidated Balance Sheets
Balance at June 30,20262025
(In millions)
Cash and cash equivalents$1,700$1,677
Cash and cash equivalents held in a fiduciary capacity12,20311,871
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity$13,903$13,548
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.